SCA
WST icon

Strategic Capital Alternatives’s West Pharmaceutical WST Stock Holding History

Strategic Capital Alternatives’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		$1.47M Buy
27,216
+3,688
+16% +$215K 0.31% 98
2015
Q2 		$1.38M Buy
23,528
+457
+2% +$25.5K 0.33% 92
2015
Q1 		$1.39M Buy
23,071
+9,904
+75% +$528K 0.35% 90
2014
Q4 		$701K Buy
+13,167
New +$659K 0.27% 92

Other funds holding WST

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Strategic Capital Alternatives's WST Position: Q3 2015 in Review

Strategic Capital Alternatives increased its West Pharmaceutical (WST) stake by 16% in Q3 2015, buying an estimated $215K and bringing the position to 27,216 shares worth $1.47M. The position accounts for 0.31% of the portfolio, ranked #98.

Strategic Capital Alternatives first reported a position in WST in Q4 2014 and has held it in 4 quarters since. 248 funds tracked by Wall St. Rank hold WST as of Q3 2015.

  • Strategic Capital Alternatives held 27,216 shares of West Pharmaceutical worth $1.47M as of Q3 2015.
  • Strategic Capital Alternatives bought 3,688 West Pharmaceutical shares in Q3 2015, an estimated $215K.
  • West Pharmaceutical made up 0.31% of Strategic Capital Alternatives's portfolio in Q3 2015, its #98 holding.
  • Strategic Capital Alternatives first reported a position in West Pharmaceutical in Q4 2014 and has held it in 4 quarters since.
  • 248 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2015.

Based on Strategic Capital Alternatives's 13F filing for Q3 2015, filed 16 Nov 2015.